Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma.
AK5 antibodies
Brain MRI
Glioma
Limbic encephalitis
Neuronal antibodies
Journal
Neuroradiology
ISSN: 1432-1920
Titre abrégé: Neuroradiology
Pays: Germany
ID NLM: 1302751
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
31
01
2019
accepted:
04
04
2019
pubmed:
28
4
2019
medline:
21
1
2020
entrez:
28
4
2019
Statut:
ppublish
Résumé
Radiological hallmark of autoimmune limbic encephalitis (LE) is a hyperintense signal in MRI T2-weighted images of mesial temporal structures. We aimed to identify conventional magnetic resonance imaging (MRI) features that can help distinguish LE from temporal glioma. Brain MRIs of 25 patients affected by antibody-positive autoimmune LE, 24 patients affected by temporal glioma (tumor group), and 5 negative controls were retrospectively blindly evaluated in random order. Ten brain MRIs from the LE group were correctly recognized; one additional patient with mesial temporal hyperintensity with anti-AK5 abs LE was wrongly diagnosed as having a tumor. The brain MRIs of the remaining 14 of the 25 patients with LE were judged negative or, in three cases, showed features not typical for LE. In the tumor group, all MRIs showed pathological alterations diagnosed as tumors in 22/24 cases and as LE in two (2/22, 9%). Unilateral lesions were more common in tumors than in neuroradiologically abnormal LE (96% vs. 18%, p < 0.001). T2/FLAIR hyperintensity of the parahippocampal gyrus was associated more with tumor than with LE (71% vs. 18%) (p = 0,009), as T2/FLAIR hyperintensity of extralimbic structures (p = 0.015), edema (p = 0.041), and mass effect (p = 0.015). Maintenance of gray/white matter distinction was strongly associated with LE (91% vs. 17%, p < 0.001). Conventional brain MRI is a fundamental tool in the differential diagnosis between LE and glioma. Bilateral involvement and maintenance of gray/white matter distinction at the cortical/subcortical interface are highly suggestive of LE.
Identifiants
pubmed: 31028423
doi: 10.1007/s00234-019-02212-1
pii: 10.1007/s00234-019-02212-1
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
853-860Références
Radiology. 2000 May;215(2):470-5
pubmed: 10796927
Brain. 2000 Jul;123 ( Pt 7):1481-94
pubmed: 10869059
AJNR Am J Neuroradiol. 2001 Jun-Jul;22(6):1149-60
pubmed: 11415912
Neurology. 2003 Jan 28;60(2):230-4
pubmed: 12552036
Neuroradiology. 2006 Jun;48(6):380-6
pubmed: 16586118
J Neuroimmunol. 2007 May;186(1-2):177-80
pubmed: 17462746
Acta Neurol Scand. 2008 Nov;118(5):339-42
pubmed: 18384457
Brain. 2008 Oct;131(Pt 10):2553-63
pubmed: 18687732
Pract Neurol. 2009 Apr;9(2):90-5
pubmed: 19289559
Neurologist. 2009 Jul;15(4):208-11
pubmed: 19590380
Intern Med. 2010;49(13):1307-10
pubmed: 20606365
Neuroradiology. 2011 Nov;53(11):837-51
pubmed: 21271243
Neurologia. 2009 Sep;24(7):500-1
pubmed: 21469259
Radiology. 1990 Feb;174(2):411-5
pubmed: 2153310
AJNR Am J Neuroradiol. 2014 Jan;35(1):77-83
pubmed: 23868151
AJNR Am J Neuroradiol. 2014 Jan;35(1):84-9
pubmed: 23868165
Epilepsia. 2013 Sep;54(9):1679-87
pubmed: 23889589
Eur J Neurol. 2013 Dec;20(12):1566-70
pubmed: 23941332
Case Rep Neurol Med. 2014;2014:458790
pubmed: 24716020
Surg Oncol Clin N Am. 2014 Oct;23(4):629-84
pubmed: 25246045
Neuroradiology. 2015 Dec;57(12):1203-9
pubmed: 26293130
J Neuroimmunol. 2015 Oct 15;287:31-5
pubmed: 26439959
Neurol Neuroimmunol Neuroinflamm. 2015 Oct 01;2(6):e161
pubmed: 26468474
Lancet Neurol. 2016 Apr;15(4):391-404
pubmed: 26906964
Neurology. 2016 May 3;86(18):1692-9
pubmed: 27037230
Pract Neurol. 2016 Oct;16(5):376-80
pubmed: 27247429
Neurology. 2016 Aug 2;87(5):521-8
pubmed: 27371488
Neurology. 2016 Oct 4;87(14):1449-1456
pubmed: 27590293
JAMA Neurol. 2017 Jan 1;74(1):50-59
pubmed: 27893017
Neurology. 2017 Feb 7;88(6):514-524
pubmed: 28062719
Neuroradiology. 2018 Feb;60(2):189-198
pubmed: 29255919
J Neurol. 2018 Mar;265(3):669-677
pubmed: 29383516
Ann Neurol. 1997 Feb;41(2):238-46
pubmed: 9029073